This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2010 Remove Pharma Remove Prescription Remove Prospecting
article thumbnail

Navigating the Challenges of Biopharma Product Launches: A Blueprint for Success

PM360

FEBRUARY 1, 2024

The landscape is highly competitive with new prescription medications launching worldwide each year. Pharma is slowly evolving in its approaches to evidence generation, but it needs to accelerate to meet the new demands for launch success.” However, this journey is fraught with challenges as revealed by an in-depth analysis.

Biopharma 59
Biopharma Competition Prescription Marketing 59
article thumbnail

Humira biosimilars set the stage for long-awaited 2023 US launches

Pharmaceutical Technology

DECEMBER 4, 2022

Others are made by big pharma giants like Boehringer Ingelheim , Novartis , or Pfizer , which has raised the expectations for a competitive market. . We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects.

Marketing 104
Marketing Physicians Competition Patients 104
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024